Aptamer-based therapeutic approaches to target cancer wtem cells
Zhou, Gang, Latchoumanin, Olivier, Bagdesar, Mary, Hebbard, Lionel, Duan, Wei, Liddle, Christopher, George, Jacob, and Qiao, Liang (2017) Aptamer-based therapeutic approaches to target cancer wtem cells. Theranostics, 7 (16). pp. 3948-3961.
|
PDF (Published Version)
- Published Version
Available under License Creative Commons Attribution Non-commercial. Download (2MB) | Preview |
Abstract
Cancer stem cells (CSCs) are believed to be a principal cellular source for tumour progression and therapeutic drug resistance as they are capable of self-renewal and can differentiate into cancer cells. Importantly, CSCs acquire the ability to evade the killing effects of cytotoxic agents through changes at the genetic, epigenetic and micro-environment levels. Therefore, therapeutic strategies targeting CSCs hold great potential as an avenue for cancer treatment. Aptamers or "chemical antibodies" are a group of single-stranded nucleic acid (DNA or RNA) oligonucleotides with distinctive properties such as smaller size, lower toxicity and less immunogenicity compared to conventional antibodies. They have been frequently used to deliver therapeutic payloads to cancer cells and have achieved encouraging anti-tumour effects. This review discusses progress in CSC evolution theory and the role of aptamers to target CSCs for cancer treatment. Challenges of aptamer-mediated CSC targeting approaches are also discussed.
Item ID: | 51259 |
---|---|
Item Type: | Article (Research - C1) |
ISSN: | 1838-7640 |
Keywords: | aptamers, CSCs, cancer, drug resistance, antibodies, nanoparticles |
Additional Information: | This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
Funders: | University of Sydney (US), Cancer Council of New South Wales (CC) |
Projects and Grants: | US Robert W. Storr Bequest, CC grant APP1070076 |
Date Deposited: | 18 Oct 2017 07:37 |
FoR Codes: | 32 BIOMEDICAL AND CLINICAL SCIENCES > 3211 Oncology and carcinogenesis > 321111 Solid tumours @ 100% |
SEO Codes: | 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920102 Cancer and Related Disorders @ 100% |
Downloads: |
Total: 916 Last 12 Months: 5 |
More Statistics |